Literature DB >> 1159007

Quantitative assay of diclofenac in biological material by gas-liquid chromatography.

U P Geiger, P H Degen, A Sioufi.   

Abstract

Diclofenac and an internal standard are isolated from biological samples by acid-specific extraction and converted into the corresponding indolones with 0.5% sulphuric acid in 2,2,2-trifluorethanol. The neutral derivatives are isolated by solvent extraction and subjected to gas-liquid chromatography. The use of an electron capture detector permits the assay of diclofenac at levels down to 2 ng per sample.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159007     DOI: 10.1016/s0021-9673(00)99277-x

Source DB:  PubMed          Journal:  J Chromatogr


  16 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

2.  The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration.

Authors:  J V Willis; D B Jack; M J Kendall; V A John
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

Review 3.  Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy.

Authors:  K McCormack; K Brune
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 5.  Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury.

Authors:  B H McCarberg; C E Argoff
Journal:  Int J Clin Pract       Date:  2010-10       Impact factor: 2.503

6.  Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.

Authors:  J Radermacher; D Jentsch; M A Scholl; T Lustinetz; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

7.  Comparative bioavailability of diclofenac hydroxyethylpyrrolidine vs diclofenac sodium in man.

Authors:  C A Maggi; P Lualdi; G Mautone
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

9.  A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium.

Authors:  J V Willis; M J Kendall; D B Jack
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

10.  The pharmacokinetics of diclofenac sodium following intravenous and oral administration.

Authors:  J V Willis; M J Kendall; R M Flinn; D P Thornhill; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.